AQR Capital Management - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$650,211
-12.3%
59,380
+6.0%
0.00%
-50.0%
Q2 2023$741,361
-69.2%
55,994
-68.3%
0.00%
-60.0%
Q1 2023$2,406,547
-39.1%
176,822
-12.6%
0.01%
-44.4%
Q4 2022$3,951,759
-42.5%
202,343
-43.9%
0.01%
-47.1%
Q3 2022$6,875,000
-25.0%
360,881
-18.9%
0.02%
-19.0%
Q2 2022$9,169,000
+141.3%
445,110
+276.9%
0.02%
+200.0%
Q1 2022$3,800,000118,0850.01%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders